D
PharmaCorp Rx Inc. PCRX.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 3.18M 2.79M 3.14M 809.70K 213.00K
Total Other Revenue -- -- -- -- --
Total Revenue 3.18M 2.79M 3.14M 809.70K 213.00K
Cost of Revenue 1.91M 1.66M 1.95M 505.20K 140.90K
Gross Profit 1.26M 1.13M 1.19M 304.60K 72.10K
SG&A Expenses 1.37M 842.00K 800.50K 1.07M 497.80K
Depreciation & Amortization 136.30K 130.60K 136.80K 55.60K 16.40K
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 3.42M 2.63M 2.89M 1.63M 655.10K
Operating Income -239.00K 159.00K 255.90K -817.80K -442.10K
Income Before Tax -164.60K 252.30K 440.20K -716.20K -434.30K
Income Tax Expenses 114.20K 75.10K -76.50K 600.00 -200.00
Earnings from Continuing Operations -278.80K 177.20K 516.70K -716.80K -434.20K
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings 1.20K -8.60K 25.80K 1.30K -1.20K
Net Income -277.60K 168.60K 542.40K -715.50K -435.40K
EBIT -239.00K 159.00K 255.90K -817.80K -442.10K
EBITDA -118.90K 274.00K 376.70K -780.80K -433.90K
EPS Basic 0.00 0.00 0.00 -0.01 -0.01
Normalized Basic EPS 0.00 0.00 0.00 0.00 0.00
EPS Diluted 0.00 0.00 0.00 -0.01 -0.01
Normalized Diluted EPS 0.00 0.00 0.00 0.00 0.00
Average Basic Shares Outstanding 117.30M 115.30M 117.54M 113.16M 55.64M
Average Diluted Shares Outstanding 117.30M 115.30M 117.54M 113.16M 55.64M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --